Trials / Conditions / Pulmonary Embolism (PE)

Pulmonary Embolism (PE)

18 registered clinical trials studyying Pulmonary Embolism (PE) — 5 currently recruiting.

Status	Trial	Sponsor	Phase
Recruiting	Repeated Examinations for Typing Pulmonary Embolism NCT07491094	Sahlgrenska University Hospital	—
Recruiting	Pulmonary Embolism and Right-to-Left Shunts NCT07519876	Tufts Medical Center	—
Active Not Recruiting	Effectiveness and Cost-effectiveness of VTE Prevention Strategies in Gynecological Surgery NCT07455253	Affiliated Hospital of Nantong University	—
Recruiting	Acostream Use in Patients With High Risk and Intermediate-risk Acute Pulmonary Embolism NCT06946732	RenJi Hospital	N/A
Completed	Pulmonary Embolism Following Viper's Bites: A Case Report NCT07009301	Younes Oujidi	—
Recruiting	ULTRAsound-assisted Catheter-guided Thrombolysis for Intermediate-high Risk Patients With PE NCT07452991	National Medical Research Center for Cardiology, Ministry of Health of Russian Federation	N/A
Completed	To Compare and Evaluate the Oral Bioavailability of Edoxaban 60 mg Film Coated Tablet With That of Lixiana® 60 NCT06930937	Humanis Saglık Anonim Sirketi	N/A
Active Not Recruiting	Ultrasound Assessment of Isolated Distal Deep Vein Thrombosis NCT06596941	Ruijin Hospital	—
Completed	Repositioning the Bolus Tracking ROI to the Superior Vena Cava in CTPA Facilitates Contrast Volume Reduction NCT07342374	Hospital Queen Elizabeth, Malaysia	N/A
Completed	The Study of How Long Participants Stay in the Hospital After Receiving Apixaban for a Blood Clot in the Lung NCT03595891	Bristol-Myers Squibb	—
Completed	Direct Oral Anticoagulants (DOACs) Versus LMWH +/- Warfarin for VTE in Cancer NCT02744092	Alliance Foundation Trials, LLC.	N/A
Completed	Evaluation of Soluble Fibrin in Thrombosis Exclusion NCT02523937	Diagnostica Stago R&D	—
Completed	Cancer Venous Thromboembolism (VTE) NCT02073682	Daiichi Sankyo	Phase 3
Completed	Soluble Fibrin for Diagnosing Pulmonary Embolism NCT02438462	Diagnostica Stago R&D	—
Completed	Treatment of Venous Thromboembolism (VTE) With Either Rivaroxaban or Current Standard of Care Therapy NCT02210819	Bayer	—
Recruiting	VTEval Project - Prospective Cohort Studies to Evaluate and Improve Diagnostics, Management Strategies and Ris NCT02156401	Johannes Gutenberg University Mainz	—
Completed	Comparative Investigation of Low Molecular Weight (LMW) Heparin/Edoxaban Tosylate (DU176b) Versus (LMW) Hepari NCT00986154	Daiichi Sankyo	Phase 3
Completed	Deep Vein Thrombosis (DVT) Prevention in Total Hip Arthroplasty: Continuous Enhanced Circulation Therapy (CECT NCT00358735	Medical Compression Systems	N/A